St John’s wort (Hypericum perforatum) versus sertraline and placebo in major depressive disorder: continuation data from a 26-week RCT By Guilherme GuainJune 30, 2022
Subchronic treatment with St John’s wort produces a positive shift in emotional processing in healthy volunteers By Guilherme GuainJune 30, 2022
Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial By Guilherme GuainJune 30, 2022
The effects of tea on psychophysiological stress responsivity and post-stress recovery: a randomised double-blind trial By Guilherme GuainJune 30, 2022
Role in depression of a multi-fractionated versus a conventional Hypericum perforatum extract By Guilherme GuainJune 30, 2022
Efficacy of St. John’s wort extract WS 5570 in major depression: a double-blind, placebo-controlled trial By Guilherme GuainJune 30, 2022
Efficacy of Hypericum extract WS(®) 5570 compared with paroxetine in patients with a moderate major depressive episode – a subgroup analysis By Guilherme GuainJune 30, 2022
Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression–a double-blind, randomized, placebo controlled long-term trial By Guilherme GuainJune 30, 2022
St. John’s wort may improve some symptoms of attention-deficit hyperactivity disorder By Guilherme GuainJune 30, 2022
